Theravance Biopharma Inc. (TBPH) stock declines during after-hour. Here’s the update
Theravance Biopharma Inc. (NASDAQ: TBPH) stock gained by 0.85% at last close whereas the TBPH stock price fell by 25.19% during after-hours trading. Theravance Biopharma is a pharmaceutical firm that specializes in the research, development, and marketing of organ-specific medications. Its goal is to usher in a new generation of small molecule medicines that are […]
Here’s to why Cara Therapeutics Inc. (CARA) stock rises during after-market?
Cara Therapeutics Inc. (NASDAQ: CARA) stock gained by 4.23% at last close while the CARA stock price surges by 26.05% in the after-hours trading session. Cara Therapeutics is a clinical-stage pharmaceutical business focusing on discovering and selling novel chemical entities that address peripheral kappa opioid receptors, or KORs, to relieve pruritus. >> 7 Top Picks […]
Vivos Therapeutics Inc. (VVOS) stock rises during current market trading. Here’s to see why?
Vivos Therapeutics Inc. (NASDAQ: VVOS) stock gained by 72.39% in the current market trading session. Vivos Therapeutics is a medical technology business specializing in the development and commercialization of novel diagnostic and therapy methods for adult patients with mild to severe obstructive sleep apnea. >> 7 Top Picks for the Post-Pandemic Economy << What’s happening […]
Sphere 3D Inc. (ANY) stock soars during current market. Let’s find out why?
Sphere 3D Inc. (NASDAQ: ANY) stock gained by 11.98% at last close while the ANY stock price surges by 10.20% in the current market trading session. Through its worldwide distributor system and business services group, Sphere 3D Corp. provides containerization, virtualization, and data management solutions for hybrid cloud, cloud, and on-premise deployments. >> 7 Top […]
Orphazyme Inc. (ORPH) stock soars during pre-market trading session. Here’s to know why?
Orphazyme Inc. (NASDAQ: ORPH) stock gained by 4.16% at last close while the ORPH stock price surges by 15.17% in the pre-market trading. Orphazyme is a late-stage pharmaceutical startup working on arimoclomol for the treatment of Niemann-Pick disease. Orphazyme is based in Denmark, with offices in the United States and Switzerland. >> 7 Top Picks […]
Here’s to why Plus Therapeutics Inc. (PSTV) stock soars during pre-market trading?
Plus Therapeutics Inc. (NASDAQ: PSTV) stock gained by 0.52% at last close while the PSTV stock price surges by 12.37% in the pre-market trading session. Plus Therapeutics is a medical pharmaceutical company whose radiotherapeutic portfolio is focused on nanoliposome-encapsulated radionuclides for a variety of cancer targets. >> 7 Top Picks for the Post-Pandemic Economy << […]
Meten EdtechX Inc. (METX) stock plunges during pre-market trading session. Here’s what’s happening?
Meten EdtechX Inc. (NASDAQ: METX) stock declined by 2.26% at last close. The company declined further by 1.54% in premarket trading today. Meten EdtechX is a prominent English language and skill enhancement company in China, providing English language and skills training to Chinese students and professionals. >> 7 Top Picks for the Post-Pandemic Economy << […]
CytoSorbents Inc. (CTSO) stock plunges during after-hour trading, given no current update.
CytoSorbents Inc. (NASDAQ: CTSO) stock gained by 7% at last close whereas the CTSO stock price declines by 5.53% in the after-hours trading. CytoSorbents Corporation is a pioneer in the use of blood purification to address life-threatening diseases in critical care and heart surgery. >> 7 Top Picks for the Post-Pandemic Economy << CTSO stock’ […]
Yunhong CTI Ltd. (CTIB) stock during after-hour, despite any current update.
Yunhong CTI Ltd. (NASDAQ: CTIB) stock gained by 5.23% at last close while the CTIB stock-price surges by 14.37% in the after-hours trading session. Yunhong CTI is a prominent foil balloon maker and marketer, as well as a producer of laminated and printed commercial films. Yunhong CTI also sells Candy Blossoms and other gifts and […]
Here’s to why Azurrx Biopharma Inc. (AZRX) stock plunges during current market trading?
Azurrx Biopharma Inc. (NASDAQ: AZRX) stock falls by 3.35% in the current market trading session. AzurRx BioPharma is a medical pharmaceutical business focused on developing non-systemic, tailored treatments for gastrointestinal (GI) disorders. AZRX stock’ Significant Development AzurRx BioPharma confirmed recently that the Phase 2 Combination Trial assessing MS1819 in conjunction with the standard treatment, porcine-derived […]